Evidence map›Paper›PMID 31955444›Full record

ArticleMedical physics2020

A DNA damage multiscale model for NTCP in proton and hadron therapy.

Ramin Abolfath, Chris Peeler, Dragan Mirkovic, Radhe Mohan, David Grosshans

Open access · greenAbstract read
In one paragraph

Article in Medical physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ramin AbolfathDepartment of Radiation Physics and Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 75031, USA.
Chris PeelerDepartment of Radiation Physics and Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 75031, USA.
Dragan MirkovicDepartment of Radiation Physics and Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 75031, USA.
Radhe MohanDepartment of Radiation Physics and Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 75031, USA.
David GrosshansDepartment of Radiation Physics and Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 75031, USA.
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Project 3: Enhanced Sensitivity of Tumors to Proton Beam Therapy: Mechanisms and Biomarkers.P01CA261669 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HONG, THEODORE S · 2021 to 2025
$14.0M
MDACC Clinical and Research Physics SupportU19CA021239 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MOHAN, RADHE · 2014 to 2018
$11.2M
NCI NIH HHS P01 CA261669NCI NIH HHS P30 CA016672NCI NIH HHS U19 CA021239
6 · The paper itself

Abstract

purposeTo develop a first principle and multiscale model for normal tissue complication probability (NTCP) as a function of dose and LET for proton and in general for particle therapy with a goal of incorporating nanoscale radio-chemical to macroscale cell biological pathways, spanning from initial DNA damage to tissue late effects.

methodsThe method is a combination of analytical and multiscale computational steps including (a) derivation of functional dependencies of NTCP on DNA-driven cell lethality in nanometer and mapping to dose and LET in millimeter, and (b) three-dimensional-surface fitting to Monte Carlo data set generated based on postradiation image change and gathered for a cohort of 14 pediatric patients treated by scanning beam of protons for ependymoma. We categorize voxel-based dose and LET associated with development of necrosis in NTCP.

resultOur model fits well the clinical data, generated for postradiation tissue toxicity and necrosis. The fitting procedure results in extraction of in vivo radio-biological α-β indices and their numerical values. DISCUSSION AND

conclusionThe NTCP model, explored in this work, allows to correlate the tissue toxicities to DNA initial damage, cell lethality and the properties and qualities of radiation, dose, and LET.

Indexed as

DNA DamageModels, BiologicalProton TherapyEpendymomaHumanshadron therapymachine learningproton therapyradio-biologytissue toxicity

Identifiers

PMID31955444
PMCPMC10015418
OpenAlexW2999083865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.